Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

•Baseline maximum tumor diameter is an important predictor of relapse for patients with ES-HL achieving complete metabolic remission.•Patients with baseline tumor size ≥5 cm have worse outcomes with ABVD alone and are likely to benefit from consolidation radiotherapy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood advances 2020-01, Vol.4 (1), p.203-206
Hauptverfasser: Illidge, Tim M., Phillips, Elizabeth H., Counsell, Nicholas, Pettengell, Ruth, Johnson, Peter W.M., Culligan, Dominic J., Popova, Bilyana, Clifton-Hadley, Laura, McMillan, Andrew, Hoskin, Peter, Barrington, Sally F., Radford, John
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic Combined Chemotherapy Protocols
Hodgkin Disease - diagnostic imaging
Hodgkin Disease - drug therapy
Humans
Positron-Emission Tomography
Progression-Free Survival
Stimulus Report
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Baseline maximum tumor diameter is an important predictor of relapse for patients with ES-HL achieving complete metabolic remission.•Patients with baseline tumor size ≥5 cm have worse outcomes with ABVD alone and are likely to benefit from consolidation radiotherapy.
ISSN:2473-9529
2473-9537
DOI:10.1182/bloodadvances.2019001023